Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Mar 10, 2009

Premium

Febit this week said that its microRNA Geniom biochips have been updated to reflect the updated content of miRBase version 13.0, which was released by the Wellcome Trust Sanger Institute this week.

MiRBase 13.0 contains 9,539 entries, compared to 8,619 in version 12.0, launched last September. It contains 937 new hairpin sequences, and 1,004 novel mature miR and miR* products have been added, Febit said.

Febit's biochips are available as catalog products for use on its RT Analyzer instrument, via its profiling service, and also can be synthesized by labs that own one of the firm's Geniom instruments.


DNAStar this week launched ArrayStar version 3.0, which includes new functionality in the areas of normalization, gene ontology, and data transformations, the firm said.

The software also has an optional module called QSeq that is designed to accept sequence data from second-generation sequencing platforms and use it in digital gene expression and RNA-Seq applications, DNAStar said.


Premier Biosoft has launched AlleleID version 7.01. The software analysis tool for qPCR and microarray oligonucleotide design now includes support for the latest design guidelines laid down by MRC-Holland, the Dutch provider of multiplex ligation-dependent probe amplification technology.

AlleleID now also supports the UCSC genome browser file format, developed and maintained by the Genome Bioinformatics Group at the University of California at Santa Cruz. Premier said that AlleleID 7.01 includes an enhanced automatic homology avoidance algorithm that enables users to design assays with greater specificity, avoiding unrelated SNPs at the same time.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.